CS221288B2 - Method of making the heterocyclic compounds - Google Patents

Method of making the heterocyclic compounds Download PDF

Info

Publication number
CS221288B2
CS221288B2 CS811644A CS164481A CS221288B2 CS 221288 B2 CS221288 B2 CS 221288B2 CS 811644 A CS811644 A CS 811644A CS 164481 A CS164481 A CS 164481A CS 221288 B2 CS221288 B2 CS 221288B2
Authority
CS
Czechoslovakia
Prior art keywords
dibenzo
chloro
enantiomers
dihydro
compounds
Prior art date
Application number
CS811644A
Other languages
Czech (cs)
English (en)
Inventor
Gerhard Walther
Claus S Schneider
Karl-Heinz Weber
Armin Fugner
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of CS221288B2 publication Critical patent/CS221288B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/20—Dibenz [b, e] azepines; Hydrogenated dibenz [b, e] azepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D267/20—[b, f]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16—[b, f]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CS811644A 1980-03-08 1981-03-06 Method of making the heterocyclic compounds CS221288B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803008944 DE3008944A1 (de) 1980-03-08 1980-03-08 Dibenzimidazoazepine, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
CS221288B2 true CS221288B2 (en) 1983-04-29

Family

ID=6096617

Family Applications (2)

Application Number Title Priority Date Filing Date
CS811644A CS221288B2 (en) 1980-03-08 1981-03-06 Method of making the heterocyclic compounds
CS914104A CS410491A3 (en) 1980-03-08 1991-12-27 Heterocyclic derivatives, process of their preparation and pharmaceutical containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
CS914104A CS410491A3 (en) 1980-03-08 1991-12-27 Heterocyclic derivatives, process of their preparation and pharmaceutical containing them

Country Status (29)

Country Link
US (1) US4313931A (no)
EP (1) EP0035749B1 (no)
JP (1) JPS56139484A (no)
AU (1) AU535359B2 (no)
BG (1) BG33886A3 (no)
CA (1) CA1150253A (no)
CS (2) CS221288B2 (no)
DD (1) DD156708A5 (no)
DE (2) DE3008944A1 (no)
DK (1) DK154299C (no)
ES (1) ES8301481A1 (no)
FI (1) FI70898C (no)
GB (1) GB2071095B (no)
GR (1) GR74805B (no)
HK (1) HK63186A (no)
HU (1) HU180628B (no)
IE (1) IE51015B1 (no)
IL (1) IL62309A (no)
MX (1) MX6869E (no)
NO (1) NO162073C (no)
NZ (1) NZ196446A (no)
PH (1) PH15839A (no)
PL (1) PL132141B1 (no)
PT (1) PT72631B (no)
RO (1) RO81652B (no)
SU (1) SU1015829A3 (no)
UA (1) UA8041A1 (no)
YU (1) YU42557B (no)
ZA (1) ZA811500B (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ302483B6 (cs) * 1999-11-12 2011-06-08 Boehringer Ingelheim International Gmbh Vodný roztok s obsahem epinastinu

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3134672A1 (de) * 1981-09-02 1983-03-17 Boehringer Ingelheim KG, 6507 Ingelheim Heterocyclische verbindungen, ihre herstellung und verwendung
EP0130202A1 (en) * 1982-12-30 1985-01-09 Beecham Group Plc Tetracyclic compounds
DE4102148A1 (de) * 1991-01-25 1992-07-30 Boehringer Ingelheim Kg Verfahren zur herstellung von 3-amino-9,13b-dihydro-1h-dibenz-(c,f)imidazol(1,5-a)azepin-hydrochlorid
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne
DE19958460A1 (de) * 1999-12-03 2001-06-07 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US20100310477A1 (en) * 2000-11-28 2010-12-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical compositions based on anticholingerics and additional active ingredients
DE10152973A1 (de) * 2001-10-26 2003-05-08 Boehringer Ingelheim Int Neue trockene und wässrige Epinastin-Sirup-Formulierung
JP4298212B2 (ja) * 2002-03-29 2009-07-15 大日本印刷株式会社 塩酸エピナスチン高融点型結晶の製造法
DK1496051T3 (da) * 2002-04-11 2007-03-26 Konica Minolta Chemical Co Ltd Fremgangsmåde til fremstilling af 6-aminomethyl-6,11-dihydro-5H-dibenz[b,e]azepin
JP4514017B2 (ja) * 2003-03-27 2010-07-28 大日本印刷株式会社 塩酸エピナスチンの製造方法
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
ES2704482T3 (es) 2004-11-24 2019-03-18 Meda Pharmaceuticals Inc Composiciones que comprenden azelastina y sus métodos de uso
US20090143359A1 (en) * 2005-07-08 2009-06-04 Akiharu Isowaki Percutaneously Absorptive Ophthalmic Preparation Comprising Epinastine
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
KR101386530B1 (ko) 2006-12-29 2014-04-18 케이피엑스 라이프사이언스 주식회사 순도 및 수율이 향상된3-아미노-9,13ｂ디하이드로-1Ｈ-디벤즈-[ｃ,ｆ]이미다조[1,5-ａ]-아제핀 염산염의 제조방법
WO2009063504A2 (en) * 2007-09-24 2009-05-22 Usv Limited Novel crystal modification of epinastine or salts thereof and process for preparation thereof
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
JP2010120960A (ja) * 2010-02-17 2010-06-03 Dainippon Printing Co Ltd 塩酸エピナスチンの製造方法
JP6006634B2 (ja) * 2011-12-28 2016-10-12 東和薬品株式会社 イソウレア化合物を用いるエピナスチンの製造方法
CN103172638B (zh) * 2013-03-13 2015-09-16 北京朗依制药有限公司 一种盐酸依匹斯汀的制备方法
CN104098575B (zh) * 2013-04-15 2016-06-01 四川科瑞德凯华制药有限公司 一种盐酸依匹斯汀晶型及其制备方法和用途
KR102041389B1 (ko) 2017-12-12 2019-11-27 (주)프론트바이오 N-(9,13b-디하이드로-1H-디벤조[c,f]이미다조[1,5-a]아제핀-3-일)-2-하이드록시벤즈아미드 및 2-((9,13b-디하이드로-1H-디벤조[c,f]이미다조[1,5-a]아제핀-3-일) 카바모일)페닐 아세테이트의 화합물, 이의 제조방법 및 이를 포함하는 항염증 및 진통제 조성물
KR102080239B1 (ko) 2019-08-06 2020-02-21 한양대학교 에리카산학협력단 에피나스틴의 신규 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE789410A (fr) * 1971-10-05 1973-01-15 Akzo Nv Nieuwe imidazolidine derivaten
NL7202963A (no) * 1972-03-07 1973-09-11
NL7414038A (nl) * 1974-10-28 1976-05-03 Akzo Nv Nieuwe tetracyclische pyrrolidino derivaten.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ302483B6 (cs) * 1999-11-12 2011-06-08 Boehringer Ingelheim International Gmbh Vodný roztok s obsahem epinastinu

Also Published As

Publication number Publication date
DD156708A5 (de) 1982-09-15
YU56881A (en) 1983-10-31
JPS56139484A (en) 1981-10-30
GB2071095B (en) 1983-06-02
FI810712L (fi) 1981-09-09
DK154299B (da) 1988-10-31
PL132141B1 (en) 1985-02-28
RO81652A (ro) 1983-04-29
US4313931A (en) 1982-02-02
DK154299C (da) 1989-03-28
NO162073C (no) 1989-11-01
YU42557B (en) 1988-10-31
AU6815881A (en) 1981-09-17
PH15839A (en) 1983-04-08
AU535359B2 (en) 1984-03-15
ZA811500B (en) 1982-11-24
IL62309A (en) 1984-06-29
ES500150A0 (es) 1982-12-01
BG33886A3 (en) 1983-05-16
EP0035749B1 (de) 1984-06-06
IL62309A0 (en) 1981-05-20
PT72631B (fr) 1982-12-30
DE3008944A1 (de) 1981-09-24
RO81652B (ro) 1983-04-30
CS410491A3 (en) 1992-05-13
UA8041A1 (uk) 1995-12-26
EP0035749A1 (de) 1981-09-16
FI70898B (fi) 1986-07-18
DK103581A (da) 1981-09-09
NO162073B (no) 1989-07-24
FI70898C (fi) 1986-10-27
PL230036A1 (no) 1982-05-24
SU1015829A3 (ru) 1983-04-30
HU180628B (en) 1983-03-28
NZ196446A (en) 1984-07-06
MX6869E (es) 1986-09-11
JPH0366311B2 (no) 1991-10-16
PT72631A (fr) 1981-04-01
GR74805B (no) 1984-07-12
IE51015B1 (en) 1986-09-03
GB2071095A (en) 1981-09-16
DE3163938D1 (en) 1984-07-12
CA1150253A (en) 1983-07-19
HK63186A (en) 1986-09-05
IE810485L (en) 1981-09-08
NO810762L (no) 1981-09-09
ES8301481A1 (es) 1982-12-01

Similar Documents

Publication Publication Date Title
CS221288B2 (en) Method of making the heterocyclic compounds
US4062848A (en) Tetracyclic compounds
JPS6134426B2 (no)
US3966746A (en) Amino derivatives of pyrazolopyridine carboxamides
US20060234997A1 (en) Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia
US4735944A (en) Spiro-dioxolanes, -dithiolanes and -oxothiolanes, and their use in mental therapy
PL169092B1 (pl) Sposób wytwarzania nowych N-(aryloksyalkilo)heteroarylo-8-azabicyklo-[3.2.1] oktanów PL PL
CS207619B2 (en) Method of making the new derivatives of 5,11-dihydro-6h-pyrido 2,3-b 1,4 benzodiazepin-6-on
CS236680B2 (en) Manufacturing process of imidazoazepine,oxazepine,or thiazepine derivatives
ES2229688T3 (es) Derivados de 3,4-dihidroxi-quinolina como agentes inhibidores de la monoxido de nitrogeno sintasa (nos).
EP0607163B1 (en) NEUROLEPTIC 2-SUBSTITUTED PERHYDRO-1-H-PYRIDO[1,2-a]PYRAZINES
IL44489A (en) Quaternary salts of 11-(8-alkyl-3-nortropanyloxy)-6,11-dihydrodibenzo(b,e)thiepine derivatives,their production and pharmaceutical compositions containing them
US4012373A (en) Pyrazolo[3',4'-2,3]pyrido[4,5-e]b-benzo-1,5-diazepinones
JPS6323880A (ja) 置換されたヘキサヒドロアリ−ルキノリジン
EP0370449B1 (en) Fused heterocyclic derivatives of 1,2,3,4-tetrahydroacridine, a process for their preparation and their use as medicaments
US4778892A (en) Certain 3-selena-7-aza-bicyclo[3.3.1]nonanes as antiarrhythmic agents
US4013679A (en) Substituted 6,7-dihydro [1,7-ab](1) benzazepine compounds
EP0015786B1 (fr) Imidazo et pyrimido-pyrido-indoles, leur préparation et médicaments les contenant
US3337544A (en) 3, 8-diazabicyclooctane derivatives of phenothiazines
KR830001667B1 (ko) 페닐 퀴놀리지딘의 제조방법
JPH0473435B2 (no)
US5043445A (en) Bis-1,3-diazine heterocyclic derivatives as antiarrhythmic agents
US4980468A (en) Polyheterobicyclotridecane compounds
KR850000173B1 (ko) 사이클릭 구아니딘 유도체의 제조방법
US5268481A (en) 3-7-diheterabicyclo (3.3.1)nonanes and derivatives as antiarrhythmic agents